Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KTTA · as of Jun 8, 2026
Key Statistics
Explore Pasithea Therapeutics Corp. Data
ktta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The KTTA analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +416.62% upside from the current price of $0.58.
Competitors & Peers
ktta competitorsKTTA
AIM
CYCN
IBO
KALA
NBYStock Performance
Full HistoryAbout Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and…
what is pasithea therapeutics corp. · ktta stock overview · pasithea therapeutics corp. company profile · who is pasithea therapeutics corp. ceo · ktta NASDAQ · pasithea therapeutics corp. headquarters · pasithea therapeutics corp. business segments
About Stock Overview & Key Data
Pasithea Therapeutics Corp. (KTTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2021. As of the latest trading session, KTTA stock price is $0.58, with a market capitalization of $4.3M. The stock has returned -35.48% over the past 12 months and -54.98% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Pasithea Therapeutics Corp. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Pasithea Therapeutics Corp. reported revenue of — and net income of -$20.4M. For detailed data — including Pasithea Therapeutics Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pasithea Therapeutics Corp. (KTTA) stock price is $0.58. The stock is traded on NASDAQ under the ticker symbol KTTA. The 52-week range is $0.28 – $2.06.